10/7/2009 11:13:01 AM
October 07, 2009, California, US – Strand Life Sciences, Pioneers in Discovery
Research Informatics, today announced that, “Thon de Boer” former Sr. Product
Manager-Bioinformatics at Complete Genomics and Product manager for GeneSpring
family of products, at Agilent Technology has joined Strand as the company's Director of
Product Management, Software.
This newly created product management role is designed to expand on Strand’s current
leadership position in innovation through an increased rate of new product introductions
and expanded R&D programs. His primary responsibilities at Strand will include
managing and expanding Strand’s software product portfolio activities from concept to
customer and providing strategic direction for software product development.
"We are pleased to welcome Thon as a member of our Sr. management team, "said
said Francois Mandeville, Executive Vice President, Strand Life Sciences.” Thon has
unparalleled expertise and experience in Bioinformatics Product Development and
Programming and in-depth knowledge of many Bioinformatics software solution and we
are confident that his addition to our team will be invaluable as we continue to expand
our footprint on a global basis to meet increasing customer demand."
Thon’s outstanding resume includes over 14 years of hands-on experience in product
management, as a researcher and manager in both international research institutes and
commercial enterprises. Thon is an undergraduate in Biology and a Ph.D. in Molecular
Biology from VU University, Amsterdam. He has been instrumental in the success of
many of the standard software applications that are being used in thousands of labs all
around the world and has a passion in making the complex algorithms used in modern
Biology accessible to everyone.
About Strand Life Sciences
Strand Life Sciences – Pioneers in Discovery Research Informatics, is an innovative life
science informatics company. Strand has developed pioneering software technologies
with applications in pharmaceutical drug discovery. Over the years Strand has built
strong competencies and intellectual property in the areas of omics-based technologies,
bioinformatics, cheminformatics, predictive modeling, workflow and knowledge
With a deep understanding of the life sciences industry, commitment to innovation,
access to current and emerging technologies, mature development processes, global
resources and a proven track record, Strand provides discovery informatics solutions and
services and help its customers achieve their objectives.
Five of the top ten pharmaceutical companies, three of the top six biotechnology
companies, and numerous academic institutions across the globe, are part of Strand's
esteemed customer profile, who trust Strand for delivering solutions to complex
problems in life sciences research. Strand is a portfolio company of UTI Venture Funds,
Sequoia Capital, and MediBIC group (Japan).
For more information please visit www.strandls.com
comments powered by